Prevention Of Recurrent Preterm Delivery By 17 Alpha Hydroxyprogesterone

We have collected information about Prevention Of Recurrent Preterm Delivery By 17 Alpha Hydroxyprogesterone for you. Follow the links to find out details on Prevention Of Recurrent Preterm Delivery By 17 Alpha Hydroxyprogesterone.


Prevention of Recurrent Preterm Delivery by 17 Alpha ...

    https://www.nejm.org/doi/full/10.1056/NEJMoa035140
    The results of several small trials have suggested that 17 alpha-hydroxyprogesterone caproate (17P) may reduce the risk of preterm delivery.Author: Paul J. Meis, Mark Klebanoff, Elizabeth Thom, Mitchell P. Dombrowski, Baha Sibai, Atef H. Moawad, Ca...

Prevention of recurrent preterm delivery by 17 alpha ...

    https://www.ncbi.nlm.nih.gov/pubmed/12802023
    Jun 12, 2003 · The results of several small trials have suggested that 17 alpha-hydroxyprogesterone caproate (17P) may reduce the risk of preterm delivery. METHODS: We conducted a double-blind, placebo-controlled trial involving pregnant women with a documented history of spontaneous preterm delivery.Author: Paul J. Meis, Mark Klebanoff, Elizabeth Thom, Mitchell P. Dombrowski, Baha Sibai, Atef H. Moawad, Ca...

Prevention of recurrent preterm delivery by 17 alpha ...

    https://www.ncbi.nlm.nih.gov/pubmed/12968095
    Sep 11, 2003 · Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. Brancazio LR, Murtha AP, Heine RP. Comment …Author: Brancazio Lr, Murtha Ap, Heine Rp

(PDF) Prevention of Recurrent Preterm Delivery by 17 Alpha ...

    https://www.researchgate.net/publication/10712383_Prevention_of_Recurrent_Preterm_Delivery_by_17_Alpha-Hydroxyprogesterone_Caproate
    The results of several small trials have suggested that 17 alpha-hydroxyprogesterone caproate (17P) may reduce the risk of preterm delivery. We conducted a double-blind, placebo-controlled trial...

Experts in high-risk pregnancy respond to the published ...

    https://medicalxpress.com/news/2019-10-experts-high-risk-pregnancy-published-results.html
    Oct 25, 2019 · Reported substance use SMFM has reviewed the results of the PROLONG trial and has released the SMFM Statement: Use of 17-alpha hydroxyprogesterone caproate for prevention of recurrent preterm...

SMFM Statement: Use of 17-alpha hydroxyprogesterone ...

    https://www.smfm.org/publications/280-smfm-statement-use-of-17-alpha-hydroxyprogesterone-caproate-for-prevention-of-recurrent-preterm-birth
    SMFM Statement: Use of 17-alpha hydroxyprogesterone caproate for prevention of recurrent preterm birth. Tags: preterm birth, prior preterm birth. Categories: SMFM Statement. back Publication Files & Links. Original Article; 409 12th Street, SW. Washington, DC 20024

Searching for Prevention Of Recurrent Preterm Delivery By 17 Alpha Hydroxyprogesterone?

You can just click the links above. The data is collected for you.

Related Delivery Info